Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Treatment delivery

From: Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)

 

N = 19

Chemotherapy

 

 Cisplatin + Vinorelbine

18 (94.7%)

  3 cycles

2

  4 cycles

16

 Cisplatin + Docetaxel

1 (5.3%)

  4cycles

1

Thoracic radiotherapy

 

 60 Gy completed

19 (100%)

  Without discontinuation

10

  With discontinuation

9*

Local consolidative therapy

 

 Brain

9 (47.4%)

  Surgery

1

  Surgery + whole-brain radiotherapy

3

  Stereotactic irradiation

5

 Bone

7 (36.8%)

  Radiotherapy

7

 Adrenal grand

2 (10.5%)

  Surgery

1

  Radiotherapy

1

 Cervical lymph node

1 (5.3%)

  Surgery + radiotherapy

1

  1. *Neutrophil count decreased: 6, Febrile neutropenia: 1, other: 2